X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (22990) 22990
Book Chapter (142) 142
Magazine Article (90) 90
Publication (67) 67
Dissertation (62) 62
Conference Proceeding (15) 15
Book / eBook (8) 8
Book Review (7) 7
Newspaper Article (6) 6
Web Resource (4) 4
Streaming Video (3) 3
Government Document (2) 2
Newsletter (2) 2
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14096) 14096
male (10583) 10583
levodopa (8542) 8542
female (8378) 8378
parkinson's disease (7633) 7633
parkinson disease - drug therapy (7615) 7615
levodopa - therapeutic use (7248) 7248
middle aged (6520) 6520
clinical neurology (6483) 6483
animals (5977) 5977
aged (5891) 5891
neurosciences (5358) 5358
levodopa - pharmacology (4040) 4040
antiparkinson agents - therapeutic use (3645) 3645
adult (3447) 3447
levodopa - adverse effects (3351) 3351
rats (3105) 3105
dopamine (3043) 3043
parkinson disease - physiopathology (2921) 2921
levodopa - administration & dosage (2731) 2731
l-dopa (2662) 2662
pharmacology & pharmacy (2304) 2304
parkinsons-disease (2179) 2179
antiparkinson agents - adverse effects (2052) 2052
dopa (2011) 2011
neurology (1949) 1949
movement disorders (1802) 1802
dopamine - metabolism (1735) 1735
parkinson disease - complications (1645) 1645
parkinson’s disease (1605) 1605
basal ganglia (1604) 1604
parkinsons disease (1589) 1589
time factors (1533) 1533
dose-response relationship, drug (1499) 1499
drug therapy, combination (1486) 1486
treatment outcome (1407) 1407
dyskinesia (1380) 1380
antiparkinson agents - administration & dosage (1310) 1310
psychiatry (1300) 1300
neurodegenerative diseases (1264) 1264
levodopa - metabolism (1233) 1233
motor fluctuations (1228) 1228
mice (1164) 1164
aged, 80 and over (1121) 1121
double-blind (1115) 1115
parkinson disease - therapy (1100) 1100
analysis (1044) 1044
brain (1014) 1014
disease models, animal (979) 979
parkinson disease (972) 972
carbidopa - therapeutic use (971) 971
disease (965) 965
parkinson disease - diagnosis (954) 954
parkinson disease - metabolism (921) 921
motor activity - drug effects (916) 916
severity of illness index (914) 914
drug combinations (894) 894
deep brain stimulation (891) 891
double-blind method (888) 888
therapy (888) 888
rats, sprague-dawley (866) 866
antiparkinson agents - pharmacology (861) 861
neurons (861) 861
subthalamic nucleus (847) 847
dopamine agonists - therapeutic use (841) 841
corpus striatum - metabolism (819) 819
levodopa-induced dyskinesia (765) 765
corpus striatum - drug effects (758) 758
brain - metabolism (751) 751
phenols (747) 747
parkinson disease - psychology (737) 737
levodopa-induced dyskinesias (728) 728
follow-up studies (714) 714
nervous system diseases (710) 710
levodopa - pharmacokinetics (707) 707
dopamine agents - therapeutic use (699) 699
research (689) 689
medicine & public health (685) 685
dihydroxyphenylalanine (682) 682
biochemistry & molecular biology (680) 680
dyskinesia, drug-induced - etiology (658) 658
dopamine agents - pharmacology (650) 650
adolescent (635) 635
pharmacokinetics (629) 629
striatum (629) 629
carbidopa - administration & dosage (623) 623
surgery (622) 622
care and treatment (615) 615
diagnosis (603) 603
brain - drug effects (598) 598
parkinsonian disorders - drug therapy (591) 591
carbidopa (587) 587
drug therapy (585) 585
dopamine - physiology (577) 577
parkinsonism (576) 576
patients (576) 576
research article (574) 574
drug administration schedule (572) 572
progression (561) 561
medicine, general & internal (554) 554
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (21113) 21113
German (516) 516
Japanese (457) 457
French (432) 432
Russian (396) 396
Spanish (374) 374
Italian (160) 160
Portuguese (114) 114
Polish (98) 98
Chinese (77) 77
Hungarian (35) 35
Dutch (31) 31
Czech (22) 22
Swedish (14) 14
Norwegian (13) 13
Danish (12) 12
Finnish (12) 12
Serbian (12) 12
Hebrew (10) 10
Slovak (10) 10
Korean (9) 9
Romanian (6) 6
Turkish (6) 6
Bulgarian (4) 4
Slovenian (4) 4
Ukrainian (3) 3
Breton (2) 2
Croatian (2) 2
Persian (2) 2
Bosnian (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The AAPS journal, ISSN 1550-7416, 2012, Volume 15, Issue 2, pp. 316 - 323
Motor complications of Parkinson’s disease (PD) are a consequence of pulsatile dopaminergic stimulation from standard oral levodopa therapy. Levodopa–carbidopa... 
Biochemistry, general | Duodopa | Biotechnology | Biomedicine | Pharmacy | LCIG | Levodopa-carbidopa intestinal gel | Pharmacology/Toxicology | Pharmacokinetics | Parkinson’s disease | Parkinson's disease | ENTACAPONE | CONTINUOUS DOPAMINERGIC STIMULATION | ORAL LEVODOPA | LEVODOPA/CARBIDOPA | RELEASE | TRANSPORT | THERAPY | FLUCTUATIONS | L-DOPA | PHARMACOLOGY & PHARMACY | ABSORPTION | Humans | Middle Aged | Intubation, Gastrointestinal - instrumentation | Levodopa - pharmacokinetics | Male | Tyrosine - blood | Parkinson Disease - drug therapy | Tyrosine - analogs & derivatives | Intestinal Absorption | Jejunum - metabolism | Levodopa - chemistry | Sweden | Levodopa - administration & dosage | Biotransformation | Carbidopa - adverse effects | Antiparkinson Agents - chemistry | Female | Tyrosine - pharmacokinetics | Carbidopa - blood | Carbidopa - administration & dosage | Gels | Infusion Pumps | Carbidopa - pharmacokinetics | Carbidopa - chemistry | Antiparkinson Agents - adverse effects | Levodopa - blood | Chemistry, Pharmaceutical | Antiparkinson Agents - pharmacokinetics | Antiparkinson Agents - blood | Levodopa - adverse effects | Parkinson Disease - diagnosis | Aged | Antiparkinson Agents - administration & dosage | Parkinson Disease - blood | Drug Combinations | Germany | Complications and side effects | Neurosciences | Carbidopa | Metabolites | Universities and colleges | Dopa | Oral medication | Pharmaceutical Sciences | Basic Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper | Farmaceutiska vetenskaper
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2019, Volume 380, Issue 4, pp. 315 - 324
Journal Article
Movement disorders, ISSN 0885-3185, 2015, Volume 30, Issue 4, pp. 500 - 509
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2014, Volume 13, Issue 2, pp. 141 - 149
Journal Article
Neurological sciences, ISSN 1590-3478, 2016, Volume 37, Issue 11, pp. 1785 - 1792
Journal Article
Parkinsonism & related disorders, ISSN 1353-8020, 2015, Volume 21, Issue 8, pp. 871 - 876
Journal Article
British journal of clinical pharmacology, ISSN 0306-5251, 10/2018, Volume 84, Issue 10, pp. 2422 - 2432
Journal Article
Lancet neurology, ISSN 1474-4422, 2016, Volume 15, Issue 2, pp. 154 - 165
Journal Article
Neurobiology of disease, ISSN 0969-9961, 2017, Volume 108, pp. 54 - 64
N-methyl-d-aspartate receptor (NMDAR) subunit composition strictly commands receptor function and pharmacological responses. Changes in NMDAR subunit... 
Levodopa-induced dyskinesias | Cell-permeable peptides | N-methyl-d-aspartate receptor | Pharmacological target | N-methyl-D-aspartate receptor | DOPA-INDUCED DYSKINESIA | N-methyl-(D)-aspartate receptor | SYNAPTIC PLASTICITY | NEUROSCIENCES | RAT MODEL | NMDA-RECEPTOR | Levodopa-induced dysldnesias | D-ASPARTATE | DISEASE | DOUBLE-BLIND | AMANTADINE | MODULATION | SUBUNIT | Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors | Vesicular Transport Proteins - metabolism | Humans | Receptors, N-Methyl-D-Aspartate - metabolism | Male | Antiparkinson Agents - toxicity | Macaca mulatta | Oxidopamine | Corpus Striatum - metabolism | Antiparkinson Agents - therapeutic use | Parkinsonian Disorders - metabolism | Vesicular Transport Proteins - antagonists & inhibitors | Synapses - metabolism | Adaptor Proteins, Signal Transducing - antagonists & inhibitors | Dyskinesia, Drug-Induced - drug therapy | Parkinsonian Disorders - drug therapy | Protein Binding - drug effects | Aged, 80 and over | Female | Post-Synaptic Density - drug effects | Post-Synaptic Density - metabolism | Corpus Striatum - pathology | Nerve Tissue Proteins - antagonists & inhibitors | Synapses - drug effects | Levodopa - therapeutic use | Tissue Culture Techniques | Levodopa - toxicity | Dyskinesia, Drug-Induced - pathology | Rats, Sprague-Dawley | Nerve Tissue Proteins - metabolism | Animals | Parkinsonian Disorders - pathology | Post-Synaptic Density - pathology | Corpus Striatum - drug effects | Aged | Dyskinesia, Drug-Induced - metabolism | Adaptor Proteins, Signal Transducing - metabolism | Care and treatment | Dopa | Movement disorders | Protein-protein interactions
Journal Article